ArticleBMC medical imaging2026
Multiparametric MRI-based habitat analysis integrating deep learning and radiomics for predicting preoperative Ki-67 expression level in breast cancer.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound radiomics for preoperative evaluation of Ki-67 proliferation index in papillary thyroid carcinoma.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBreast cancer (BC) is the most common malignant tumor in women globally. Ki-67, a vital marker for prognosis, is currently detected invasively. Non-invasive magnetic resonance imaging (MRI) prediction faces challenges due to intratumoral heterogeneity. MATERIALS AND
methodsThis retrospective study included 254 breast cancer patients from two centers, divided into training set (142 patients), internal validation set (60 patients), and external test set (52 patients). T2-weighted imaging (T2WI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) were analyzed. Traditional radiomics features were extracted from intratumoral, habitat subregions, 5/10-mm peritumoral rings, image fusion. A pre-trained ResNet-50 model extracted 2.5D deep learning features. Feature selection used intraclass correlation coefficient (ICC), Z-score normalization, T-tests, Pearson correlations, and the least absolute shrinkage and selection operator (LASSO). A baseline clinical model was constructed using clinical and qualitative MRI semantic features. Models were built using Support Vector Machine (SVM), Random Forest (RF), and Extra-Trees (ET). Model performance was evaluated via the area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F-1 score. Gradient-weighted Class Activation Mapping (Grad-CAM) was applied to the final convolutional layer of ResNet50 to spatially localize the decision-critical regions. Shapley Additive Explanations (SHAP) analysis enhanced interpretability.
resultsThe best clinical model achieved an AUC of 0.666 in the validation set. The best-performing traditional radiomics model achieved an AUC of 0.825 in the internal validation set. The optimal deep learning model obtained an AUC of 0.804 in the internal validation set. The combined model, utilizing the best features from both traditional radiomics and deep learning, demonstrated superior performance with an AUC of 0.885 in the internal validation set and 0.839 in the external test set.
conclusionThe integrated model combining traditional radiomics and deep learning from MRI significantly predicts Ki-67 expression in breast cancer, enhancing preoperative prediction accuracy and interpretability for personalized treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.